Monday's Late Winners & Losers
Stocks were relatively quiet after the bell Monday despite a flowering earnings season, but among the winners was Robbins & Myers (RBN).
The Dayton, Ohio, company, which makes equipment for the pharmaceutical, energy and industrial markets, said fiscal fourth-quarter earnings jumped 64.1% year-over-year to $1.05 a share, excluding items. Analysts polled by Thomson Financial were looking for just 84 cents a share. Robbins stock added $3.66, or 6%, to $64.75.
Trucking company Werner Enterprises (WERN), based in Omaha, Neb., pocketed third-quarter income of $21.9 million, or 30 cents a share, a penny over the average Street estimate. Shares, however, were recently trading lower 0.5% to $17.50 in choppy post-bell trading.
Zila (ZILA), which makes oral-disease treatments, was in the green after narrowing its fourth-quarter continuing-operations loss to $5.8 million, or 9 cents a share, vs. 17 cents a share last year. The sole analyst's estimate called for a loss of a nickel a share, excluding items. Shares of the Phoenix-based company added 13.9% to $1.15 in light trading.On the other hand, OSI Pharmaceuticals (OSIP) slipped after reporting an "unusually high" rate of expiring product returns for its Tarceva cancer treatment, which necessitated about a $13 million reserve adjustment in the third quarter. OSI nonetheless reaffirmed its prior full-year Tarceva sales guidance of between $855 million and $860 million. Still, OSI shares fell 1.6% to $35.10. Genentech (DNA), Tarceva's U.S. distributor, was off 1% to $76.76, even though the South San Francisco, Calif., biotech posted a non-GAAP profit of 73 cents a share in that quarter. That's a penny over earnings targets. Revenue, at $2.91 billion, was a hair under.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV